Noah Berlow, PhD Chief Technology Officer at First Ascent Biomedical, Assistant Member at Children’s Cancer Therapy Development Institute
-
August 23, 2022
Using AI and Drug Testing to Design Personalized Cancer Drug Combos
With:Advanced cancer treatment often involves combining multiple drugs. But with a huge number of possible combinations, it is difficult to know which mix might work best for each patient. Here, our Curious Dr. George asks two leaders to describe how the company First Ascent Biomedical is addressing this challenge. Curious Dr. George: The U.S. Food and Drug Administration (FDA) has approved many thousands of… Read more »